Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Charpidou A, Mani M, Kokkotou E, Stournara L, Stathelou L et al (2024) Molecular diagnostics and treatment patterns in metastatic non-small cell lung cancer patients: real world evidence from Greece: LACHESIS study. Anticancer Res 44(5):2063–2072
2. Conroy M, Naidoo J (2022) Immune-related adverse events and the balancing act of immunotherapy. Nat Commun 13(392):1–4
3. Yin Q, Wu L, Han L, Zheng X, Tong R (2023) Immune-related adverse events of immune checkpoint inhibitors: a review. Front Immunol. https://doi.org/10.3389/fimmu.2023.1167975
4. Barron CC, Stefanova J, Cha Y, Elsolh K, Zereshkian A et al (2023) Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review. J Immunother Cancer 11(e006500):1–7
5. Reynolds G (2023) Rheumatic complications of checkpoint inhibitors: lessons from autoimmunity. Immunol Rev 318:51–60